Clinical Trial Update: Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Pyrazoloacridine in patients with metastatic melanoma, including intraocular and cutaneous melanoma, has completed enrollmen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intraocular Melanoma
• Melanoma of the Skin

Drugs mentioned

• Pyrazoloacridine (pyrazoloacridine)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED